These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

301 related articles for article (PubMed ID: 12791525)

  • 21. The tobacco industry's role in the 16 Cities Study of secondhand tobacco smoke: do the data support the stated conclusions?
    Barnes RL; Hammond SK; Glantz SA
    Environ Health Perspect; 2006 Dec; 114(12):1890-7. PubMed ID: 17185281
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Identifying carcinogens: the tobacco industry and regulatory politics in the United States.
    Cook DM; Bero LA
    Int J Health Serv; 2006; 36(4):747-66. PubMed ID: 17175844
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Waking a sleeping giant: the tobacco industry's response to the polonium-210 issue.
    Muggli ME; Ebbert JO; Robertson C; Hurt RD
    Am J Public Health; 2008 Sep; 98(9):1643-50. PubMed ID: 18633078
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tobacco interests or the public interest: 20 years of industry strategies to undermine airline smoking restrictions.
    Lopipero P; Bero LA
    Tob Control; 2006 Aug; 15(4):323-32. PubMed ID: 16885582
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Turning science into junk: the tobacco industry and passive smoking.
    Samet JM; Burke TA
    Am J Public Health; 2001 Nov; 91(11):1742-4. PubMed ID: 11684591
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tobacco industry use of corporate social responsibility tactics as a sword and a shield on secondhand smoke issues.
    Friedman LC
    J Law Med Ethics; 2009; 37(4):819-27. PubMed ID: 20122118
    [TBL] [Abstract][Full Text] [Related]  

  • 27. How to identify science being bent: the tobacco industry's fight to deny second-hand smoking health hazards as an example.
    De Camargo KR
    Soc Sci Med; 2012 Oct; 75(7):1230-5. PubMed ID: 22726621
    [TBL] [Abstract][Full Text] [Related]  

  • 28. "Can't stop the boy": Philip Morris' use of Healthy Buildings International to prevent workplace smoking bans in Australia.
    Chapman S; Penman A
    Tob Control; 2003 Dec; 12 Suppl 3(Suppl 3):iii107-12. PubMed ID: 14645956
    [TBL] [Abstract][Full Text] [Related]  

  • 29. "Efforts to Reprioritise the Agenda" in China: British American Tobacco's Efforts to Influence Public Policy on Secondhand Smoke in China.
    Muggli ME; Lee K; Gan Q; Ebbert JO; Hurt RD
    PLoS Med; 2008 Dec; 5(12):1729-69. PubMed ID: 19108603
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Editorial input for the right price: tobacco industry support for a sheet metal indoor air quality manual.
    Campbell R; Balbach E
    New Solut; 2013; 23(3):467-83. PubMed ID: 24401484
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [The cynical game of the tobacco industry. Many years' efforts to deny or cover-up the negative effects of tobacco are revealed by the forced publication of internal documents].
    Lambe M; Hallhagen E; Boëthius G
    Lakartidningen; 2002 Jun; 99(24):2756-62. PubMed ID: 12101604
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tobacco industry influence on science and scientists in Germany.
    Grüning T; Gilmore AB; McKee M
    Am J Public Health; 2006 Jan; 96(1):20-32. PubMed ID: 16317203
    [TBL] [Abstract][Full Text] [Related]  

  • 33. ARTIST (Asian regional tobacco industry scientist team): Philip Morris' attempt to exert a scientific and regulatory agenda on Asia.
    Tong EK; Glantz SA
    Tob Control; 2004 Dec; 13 Suppl 2(Suppl 2):ii118-24. PubMed ID: 15564214
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Scientific analysis of second-hand smoke by the tobacco industry, 1929-1972.
    Schick S; Glantz S
    Nicotine Tob Res; 2005 Aug; 7(4):591-612. PubMed ID: 16085530
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Failed promises of the cigarette industry and its effect on consumer misperceptions about the health risks of smoking.
    Cummings KM; Morley CP; Hyland A
    Tob Control; 2002 Mar; 11 Suppl 1(Suppl 1):I110-7. PubMed ID: 11893821
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The limits of competing interest disclosures.
    Bero LA; Glantz S; Hong MK
    Tob Control; 2005 Apr; 14(2):118-26. PubMed ID: 15791022
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Old ways, new means: tobacco industry funding of academic and private sector scientists since the Master Settlement Agreement.
    Schick SF; Glantz SA
    Tob Control; 2007 Jun; 16(3):157-64. PubMed ID: 17565125
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The tobacco industry and secondhand smoke: lessons from Central and South America.
    Barnoya J; Glantz SA
    Ethn Dis; 2003; 13(2 Suppl 2):S88-90. PubMed ID: 13677420
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Courtesy and the challenges of implementing smoke-free policies in Japan.
    Bialous SA; Mochizuki-Kobayashi Y; Stillman F
    Nicotine Tob Res; 2006 Apr; 8(2):203-16. PubMed ID: 16766413
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The tobacco industry's use of Wall Street analysts in shaping policy.
    Alamar BC; Glantz SA
    Tob Control; 2004 Sep; 13(3):223-7. PubMed ID: 15333876
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.